These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19185829)

  • 21. Menopausal hormone therapy after breast cancer.
    Chlebowski RT; Col N
    Lancet; 2004 Feb; 363(9407):410-1. PubMed ID: 14962515
    [No Abstract]   [Full Text] [Related]  

  • 22. Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
    Kenemans P
    Gynecol Endocrinol; 2010 Apr; 26(4):237-9. PubMed ID: 20017707
    [No Abstract]   [Full Text] [Related]  

  • 23. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
    Biglia N; Maffei S; Lello S; Nappi RE
    Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pros and cons of hormone replacement therapy.
    Brennan K; Ayres J
    Nurs Times; 2003 Sep 2-8; 99(35):26-7. PubMed ID: 14528753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormonal replacement therapy after breast cancer].
    Giacalone PL; Laffargue F
    Contracept Fertil Sex; 1994 Dec; 22(12):741-5. PubMed ID: 7827635
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer and menopause: art, science and quality of life.
    Chism L
    Adv NPs PAs; 2012 Oct; 3(10):21-4; quiz 25. PubMed ID: 23082606
    [No Abstract]   [Full Text] [Related]  

  • 29. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 30. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Only two secure indications left. Changing one's view of hormone replacement therapy].
    Fath R
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2236. PubMed ID: 14608994
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone therapy and menopause].
    Heutling D; Lehnert H
    Dtsch Med Wochenschr; 2005 Apr; 130(13):829-34. PubMed ID: 15789305
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hormone replacement therapy].
    Nozaki M
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():406-10. PubMed ID: 16689342
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of alternatives to estrogen for treatment of menopause.
    Pinkerton JV; Santen R
    Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormones--therapy for symptoms only.
    Grady D
    N Engl J Med; 2003 May; 348(19):1835-7. PubMed ID: 12642636
    [No Abstract]   [Full Text] [Related]  

  • 36. Do vaginal estrogens increase endometrial proliferation risk?
    Andreini Poulsen S
    Am Fam Physician; 2011 Aug; 84(4):354; author reply 354-5. PubMed ID: 21842780
    [No Abstract]   [Full Text] [Related]  

  • 37. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
    Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
    J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
    [No Abstract]   [Full Text] [Related]  

  • 38. Estrogen replacement therapy for the breast cancer survivor: a reappraisal.
    Disaia PJ
    J Surg Oncol; 1997 Mar; 64(3):175-80. PubMed ID: 9121146
    [No Abstract]   [Full Text] [Related]  

  • 39. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
    Kenemans P; Speroff L;
    Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does hormonal therapy decrease tamoxifen associated hot flashes?
    Barton DL; Loprinzi CL
    Breast Cancer Res Treat; 2009 Aug; 116(3):529-30. PubMed ID: 19205876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.